|
Status |
Public on Dec 05, 2018 |
Title |
Progressive sarcoidosis sample 1 [sarcexp] |
Sample type |
RNA |
|
|
Source name |
BALF
|
Organism |
Homo sapiens |
Characteristics |
group: Prog Sarc Sex: Male race: AA ethnicity: non-hispanic smoking status: Former scadding: 4 forced vital capacity, percent predicted: 88 forced expiratory volume in one second, percent predicted: 75 diffusing capacity of the lung for carbon monoxide, percent predicted: 58 age: 55 treatment: Treated 1stdrug: Steroid
|
Treatment protocol |
NA, cells were not treated prior to extraction
|
Growth protocol |
NA, primary cells used
|
Extracted molecule |
total RNA |
Extraction protocol |
Standard Qiagen AllPrep protocol
|
Label |
Cy3
|
Label protocol |
Agilent low input quick amp labeling protocol
|
|
|
Hybridization protocol |
Agilent low input quick amp labeling protocol
|
Scan protocol |
NimbleGen MS200
|
Description |
PolyA-selected total RNA extracted from BAL fluid
|
Data processing |
Agilent Feature Extraction, followed by quantile normalization and log2 transformation
|
|
|
Submission date |
Feb 18, 2018 |
Last update date |
Dec 05, 2018 |
Contact name |
Ivana Yang |
E-mail(s) |
[email protected]
|
Organization name |
University of Colorado - Anschutz Medical Campus
|
Street address |
12700 E 19th Ave
|
City |
Aurora |
State/province |
CO |
ZIP/Postal code |
80045 |
Country |
USA |
|
|
Platform ID |
GPL21185 |
Series (2) |
GSE110777 |
DNA Methylation Changes in Lung Immune Cells are Associated with Granulomatous Lung Disease [sarcexp] |
GSE110780 |
DNA Methylation Changes in Lung Immune Cells are Associated with Granulomatous Lung Disease |
|